Skip to main content
Mayinglong Pharmaceutical Group Co.,Ltd logo

Mayinglong Pharmaceutical Group Co.,Ltd — Investor Relations & Filings

Ticker · 600993 ISIN · CNE000001HN2 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 931 across all filing types
Latest filing 2021-03-25 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 600993

About Mayinglong Pharmaceutical Group Co.,Ltd

https://www.mayinglong.cn/

Mayinglong Pharmaceutical Group Co.,Ltd. is a long-established enterprise specializing in the research, development, and production of Traditional Chinese Medicine (TCM). Founded in 1582, the company is widely recognized for its expertise in proctology, maintaining a dominant market position with its signature hemorrhoid ointments and suppositories. Its product portfolio also includes ophthalmic preparations, dermatological treatments, and gastrointestinal medicines. The company integrates traditional medicinal formulas with modern manufacturing technologies to provide healthcare solutions. Beyond pharmaceuticals, Mayinglong has expanded into healthcare services, including specialized hospitals and personal care products, focusing on the integration of clinical treatment and health management.

Recent filings

Filing Released Lang Actions
马应龙关于为子公司提供贷款担保额度的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by the company 马应龙药业集团股份有限公司 regarding the provision of loan guarantees to its subsidiaries. It details the guarantee amounts, the subsidiaries involved, their financial status, and the board's approval of the guarantee. The document includes no financial statements or detailed financial performance data but focuses on a specific financing-related corporate action. It is not a full financial report, audit report, or earnings release. It is not a regulatory certification or a report publication announcement. The content fits best under Capital/Financing Update (CAP) as it concerns updates on company financing activities, specifically loan guarantees provided to subsidiaries.
2021-03-25 Chinese
马应龙关于续聘2021年度会计师事务所的公告
Audit Report / Information Classification · 90% confidence The document is an announcement regarding the company's decision to reappoint an accounting firm (中审众环会计师事务所) for the 2021 fiscal year. It details the background, qualifications, and audit fees of the accounting firm, as well as the approval process involving the board and independent directors. There is no actual audit report or financial statements included, only information about the appointment and related procedures. The document length is 2981 characters, which is relatively short and consistent with an announcement rather than a full audit report. Therefore, this document is best classified as an Audit Report / Information announcement (AR), since it pertains to audit-related information but is not a full annual report or audit report itself. However, given the document is primarily about the appointment of the auditor and not the audit report results, it aligns more closely with an Audit Report / Information (AR) category rather than a Regulatory Filing (RNS) or Report Publication Announcement (RPA). FY 2021
2021-03-25 Chinese
马应龙第十届董事会第十次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 10th meeting of the 10th Board of Directors of Mayinglong Pharmaceutical Group Co., Ltd. It includes approvals of various reports for the fiscal year 2020 such as the General Manager's Work Report, Board Work Report, Independent Directors' Report, Audit Committee Report, Financial Statements, Profit Distribution Plan, Annual Report and Summary, Internal Control Evaluation Report, Social Responsibility Report, and other related matters. The document contains substantive financial data including revenue, net profit, equity, and cash flow figures for 2020, as well as detailed descriptions of board decisions and approvals. The document is not merely an announcement of a report publication but includes actual financial results and management reports. The presence of comprehensive financial data and management discussion indicates this is an Interim / Quarterly Report type document, as it covers a period shorter than a full fiscal year (the 2020 year-end data) and includes detailed financial statements and analysis. However, since it is a year-end report with full financial data, it aligns more closely with an Annual Report (10-K) classification. But the document is a board meeting resolution announcement approving these reports, not the full annual report itself. The document is 4237 characters, which is relatively short and mainly a board meeting resolution announcement with references to where full reports are published. According to the "Menu vs Meal" rule, this is an announcement of board resolutions approving various reports, not the reports themselves. Therefore, the best classification is Board/Management Information (MANG), as it announces board meeting decisions and approvals of management and financial reports, not the reports themselves.
2021-03-25 Chinese
马应龙2020年度内部控制审计报告
Regulatory Filings
2021-03-25 Chinese
马应龙独立董事关于第十届董事会第十次会议相关事项的独立意见
Regulatory Filings
2021-03-25 Chinese
马应龙2020年年度报告
Annual Report Classification · 100% confidence The document is titled "2020 年年度报告" which translates to "2020 Annual Report". It contains detailed financial data, including revenue, net profit, cash flow, segment analysis, and management discussion. It also includes audit information with a standard unqualified opinion from an accounting firm, detailed company business overview, industry analysis, and risk disclosures. The length is substantial (15,000 characters), and the content is consistent with a full annual report rather than a brief announcement or a certification. Therefore, this document fits the definition of an Annual Report (10-K). FY 2020
2021-03-25 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.